<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<doc>
  <docno>
    <textblock>FR940105-0-00051</textblock>
  </docno>
  <parent>
    <textblock>FR940105-0-00008</textblock>
  </parent>
  <text>
    <textblock>8. Section 20.81␣</textblock>
    <textblock>Data and information previously disclosed to the public</textblock>
    <textblock>is amended in paragraph (a)(3) by removing the phrase ``part 312 of this chapter or other''.</textblock>
    <textblock>§20.85</textblock>
    <textblock>[Amended]</textblock>
    <textblock>9. Section 20.85␣</textblock>
    <textblock>Disclosure to other Federal government departments and agencies</textblock>
    <textblock>is amended in the last sentence by removing the words ``an agreement'' and adding in their place the words ``a written agreement''.</textblock>
    <textblock>10. Section 20.87 is amended by revising paragraph (a) to read as follows:</textblock>
    <textblock>§20.87</textblock>
    <textblock>Disclosure to Congress.</textblock>
    <textblock>(a) All records of the Food and Drug Administration shall be disclosed to Congress upon an authorized request.</textblock>
    <textblock>* * * * *</textblock>
    <textblock>11. Section 20.100 is amended by revising paragraphs (c)(7), (c)(14), (c)(16), and (c)(17) and by adding new paragraphs (c)(35) through (c)(40) to read as follows:</textblock>
    <textblock>§20.100</textblock>
    <textblock>Applicability; cross-reference to other regulations.</textblock>
    <textblock>* * * * *</textblock>
    <textblock>(c) *␣*␣*</textblock>
    <textblock>* * * * *</textblock>
    <textblock>(7) Food additive petitions, in §§171.1(h) and 571.1(h) of this chapter.</textblock>
    <textblock>* * * * *</textblock>
    <textblock>(14) Investigational new drug notice, in §312.130 of this chapter.</textblock>
    <textblock>* * * * *</textblock>
    <textblock>(16) Master file for a new drug application, in §312.420 of this chapter.</textblock>
    <textblock>(17) New drug application file, in §314.430 of this chapter.</textblock>
    <textblock>* * * * *</textblock>
    <textblock>(35) Premarket approval application, in §814.9 of this chapter.</textblock>
    <textblock>(36) Report of certain adverse experiences with a medical device, in §803.9 of this chapter.</textblock>
    <textblock>(37) Disqualification determination of an institutional review board, in §56.122 of this chapter.</textblock>
    <textblock>(38) Disqualification determination of a nonclinical laboratory, in §58.213 of this chapter.</textblock>
    <textblock>(39) Minutes or records regarding a public advisory committee, in §14.65(c) of this chapter.</textblock>
    <textblock>(40) Data submitted regarding persons receiving an implanted pacemaker device or lead, in §805.25 of this chapter.</textblock>
    <textblock>Dated: December 23, 1993.</textblock>
  </text>
  <signer>
    <textblock>Michael R. Taylor,</textblock>
  </signer>
  <signjob>
    <textblock>Deputy Commissioner for Policy.</textblock>
  </signjob>
  <frfiling>
    <textblock>[FR Doc. 94-98 Filed 1-4-94; 8:45 am]</textblock>
  </frfiling>
  <billing>
    <textblock>BILLING CODE 4160-01-P</textblock>
  </billing>
</doc>
